Viewing StudyNCT04658186



Ignite Creation Date: 2024-05-06 @ 3:30 PM
Last Modification Date: 2024-10-26 @ 1:51 PM
Study NCT ID: NCT04658186
Status: COMPLETED
Last Update Posted: 2024-07-05
First Post: 2020-12-01

Brief Title: A 18-month Study to Evaluate the Efficacy Safety Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinsons Disease
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Conditions & Keywords Data

Conditions:
Name
Early-stage Parkinsons Disease
Keywords:
Name View
Early-stage PD View
Early-stage parkinsons disease View
UCB0599 View
Phase 2 View